The global surgical glue market size is expected to reach USD 4.28 Billion in 2030, and register a revenue CAGR of 8.09% during the forecast period. Increasing number of road accidents leading to fractures or bone damages, rising demand for surgical glue for treating wounds of child patients, and rising number of cardiovascular diseases and cancers that have to be treated surgically are factors expected to drive market revenue growth. Furthermore, emerging research initiatives discovering robust biomedical surgical glues that allow accelerated healing of wounds is another factor expected to drive revenue growth of market from 2022 to 2030.
Surgical glues are adhesives and sealants that are used by medical practitioners and doctors while treating wounds, cuts, burns, and during surgeries. The glue is primarily used for joining tissues together that have opened either during accidental lacerations, or incisions that have been made during surgeries, such as laparoscopy. It can be made of both synthetic and natural sources. Cyanoacrylate, polymeric hydrogels, and urethane-based adhesives are commonly used synthetic types, whereas fibrin, collagen, and gelatin are natural glues. Several benefits of surgical glue such as lower rate of infection and less application time compared to other wound healing alternatives are rising demand for glues in the healthcare sector, thus supporting market revenue growth. In addition, the glue aids in relatively painless healing of wounds, compared to sutures and staples that leave marks on the skin of patients even after complete recovery. Another major factor driving revenue growth of surgical glue market is rising demand for surgical glue for treatment of child patients, which is attributed to lack of needle wounds caused by other wound closing procedures such as stitches or staple pins.
Request a Sample@ https://qyresearchmedical.com/sample/119032
Driver: Rising number of cases of road and other accidents leading to fractures, wounds, and bone damages is driving surgical glue market revenue growth
Hospitals, specialty clinics, and other medical centers are increasingly adapting surgical glues for treatment of major and minor wounds and assist in healing of fractured bones in patients of road or other severe accidents. According to the World Health Organization (WHO), every year about 1.3 million lives are lost and 20 to 30 million people endure non-fatal injuries due to road traffic crashes. One of the major reasons for fatality is inadequate care for injured, which leads to excessive blood loss and irreversible bone damage. Increasing adoption of surgical glue to lessen the time of operation and provide adhering support for cells and tissues to recover is expected to drive market revenue growth over the forecast period. Medical adhesives and sealants are essential for surgeries on lung and heart where sutures and staples can cause punctures, leading to leakage of blood. In addition, the glue can be easily applied to locations where surgical accuracy may not be achieved through sutures and staples, thus preventing damage to surrounding tissues and growth of fibrous scar tissues along incorrectly positioned suture tracks. It also reduces the time of surgery and lowers the rate of infection. These properties have led medical practitioners to increasingly adopt natural and synthetic glues.
Children are prone to injuries, minor cuts, and wounds while playing or doing outdoor activities. Blood loss due to wounds can lead to medical complications as their immune system is not fully developed. Medical-grade adhesives can lower the risk of complications and infections by joining tissue layers opened through injury. Sealants are effective for sealing off a wound or cut from external fluids or infections and aiding fast recovery. Furthermore, medical adhesives are painless and do not puncture surrounding tissues, which is increasing adoption of the glue and expected to drive market revenue growth. Some children are circumcised a few months after birth, which leads to bleeding and wound infections. Synthetic cyanoacrylate glue is used in such situations as hemostatic and bacteriostatic adhesive. Revenue growth of the market is expected to continue in coming years owing to increasing use of cyanoacrylate glues by pediatricians to prevent blood loss and bacterial infections during circumcision of children.
Cardiovascular Diseases (CVDs) include a group of heart and blood vessel disorders that is one of the leading causes of global deaths. CVD includes coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions and results in death of about 17.9 million lives each year. Surgical procedures such as coronary angioplasty, stent implantation, and coronary artery bypass surgery are recommended for treatment of patients of CVD. These procedures involve suppressing immune system during surgery which makes tissues prone to external infection. Surgical incisions are sealed using adhesives and hemostats to lower the risk of infection and blood loss. Increasing number of surgically treated CVD patients has significantly increased demand for surgical glue in hospitals and research laboratories, thereby driving market revenue growth.
Recently, studies have revealed development of an ultra-strong biomedical glue from genetically engineered polypeptides which is comparable to commercially available synthetic variants. Biocompatible and biodegradable adhesive is expected to gain significant demand owing to genetic engineering intervention that can eliminate allergic effects of natural or nature-derived adhesives and sealants. Rising demand for the glue for exhibiting robust performance for cosmetic and hemostatic applications both in vitro and in vivo is expected to drive market revenue growth.
Restraint: Concerns regarding allergic reactions in some patients treated with surgical glue is a major factor restraining market revenue growth
Surgical glues are made from natural and synthetic materials that are generally considered safe for use. However, some patients have displayed allergic reactions when treated with certain formulations, which decreases demand for surgical glue to a certain extent. Removing the glue with acetone or petroleum jelly and treating allergic region with 1% hydrocortisone topically until reaction decreases is recommended in case of an allergic reaction. A reddish rash patch is reported to persist in operated region from a few hours to a few weeks upon the use of medical glue. Higher cost of the glue compared to other wound healing procedures and slow rate of wound healing are some other factors anticipated to restrain revenue growth of surgical glue market.
The surgical glue market has grown to an extent after experiencing a setback as a result of the COVID-19 pandemic. Glue manufacturing companies are resuming supply of medical products after semi-urgent medical operations were delayed or halted during the lockdown. Increase in number of untreated neurological disorders during the pandemic period has led developers to treat diseases by implanting a 3D printed device using an adhesive to repair damaged nerves.
Product Type Outlook:
Based on type, global surgical glue market has been segmented into synthetic and semi-synthetic adhesives and sealants, and natural adhesives and sealants.
Synthetic and semi-synthetic adhesives and sealants segment is projected to register rapid revenue growth rate from 2022 to 2030. One of the major factors driving revenue growth of this segment is rising demand for cyanoacrylate adhesives by pediatricians for treatment of wounds and cuts in children. Furthermore, demand is expected to increase due to increasing number of children undergoing circumcision.
Natural adhesives and sealants segment is expected to register a steady revenue growth rate during the forecast period. Natural tissue sealants such as fibrin are used as adjuncts to sutures, ligatures, and cautery to enable final stages of blood clotting in bleeding tissues. Rising demand for natural tissue sealants in skin grafting, plastic surgery, and urologic surgery procedures is a major factor expected to drive revenue growth of this segment.
Based on application, global surgical glue market has been segmented into cardiovascular surgery, pulmonary surgery, liver and spleen lacerations, orthopedic surgery, plastic surgery, burn bleeding, wound healing, neurosurgery, and others.
Cardiovascular surgery segment is expected to register a significantly robust revenue growth over the forecast period. Increasing number of deaths due to CVDs has led to increasing number of patients undergoing cardiovascular surgeries for treatment. Using surgical hemostats minimizes blood loss post-surgery and prevents damage to surrounding tissues.
Plastic surgery segment is expected to register a rapid revenue CAGR growth over the forecast period. Natural haemostats such as fibrin serve as sealants to prevent blood loss in patients undergoing plastic surgeries. Over the years, number of men and women undergoing cosmetic procedures has increased rapidly. This is expected to increase adoption of surgical glue to a considerable extent.
Based on end-use, global surgical glue market has been segmented into hospitals, ambulatory surgical centers, specialty clinics, and others.
Hospitals segment is projected to register a rapid revenue growth from 2022 to 2030. Surgical glue is used for various medical procedures that involve incision of tissues or skin of the patient. Post-surgery, open tissues are sealed up using glues and adhesives as they take less time and have a low risk of infection. With increasing population, number of surgeries performed in hospitals is increasing which results in increasing adoption of surgical adhesives and sealants.
Ambulatory Surgical Centers (ASC) segment is expected to register a steady rate of revenue growth over the forecast period. Rising number of ASCs in urban areas over the recent years due to increasing population has led to rising demand for surgical glue for accurate and efficient treatment of patients. This is anticipated to increase revenue growth of the segment to a considerable extent.
Surgical glue market in North America is expected to account for largest revenue share during the forecast period. Presence of major manufacturers of medical adhesives in countries in this region is expected to drive market revenue growth. Moreover, recent developments in the healthcare and research sectors is expected to contribute significantly to market revenue over the forecast period.
Asia Pacific surgical glue market is expected to register a steady revenue CAGR over the forecast period due to rising number of research initiatives related to development of alternatives to suture and stitching procedures of wound sealing. Increasing number of men and women undergoing cosmetic procedures that require natural and synthetic adhesives for wound sealing are some major factors expected to drive revenue growth of surgical glue market.
Europe surgical glue market is expected to account for a steady revenue growth during the forecast period. This is due to the rapid expansion and ongoing developments in the healthcare sector. Reduced application time and low risk of infection are some factors of the glue that has led to increased usage in hospitals and specialty clinics. Furthermore, pulmonary and cardiac surgeries are increasingly adopting surgical glues, which is likely to drive the Europe market revenue growth rate.
Competitive landscape of the global surgical glue market is moderately fragmented with several key players operating on global and regional levels. Key players are engaged in platform development and strategic alliances to expand their respective portfolios and gain a robust footing in global market. Major companies in the global market report include Cryolife Inc., B. Braun Medical Inc., Medtronic PLC, Advanced Medical Solutions Group PLC, Baxter International Inc., Cohera Medical Inc., Adhesys Medical GmbH, Integra LifeSciences Holdings Corporation, Arch Therapeutics Inc., and Lifebond Machines Pvt. Ltd.
- On 16 March 2022, Braun Avitum AG, announced acquisition of Intermedt Medizin & Technik GmbH, which is a medical device and technology development company. This brings fully automated ECOMix mixing system, which has been developed by Intermedt under extensive portfolio of B. Braun Avitum division as a systems provider for dialysis (extracorporeal blood treatment). This acquisition is expected to integrate portfolios of the range of products of both companies to offer solutions and services related to dialysis from a single source.
- On 5 April 2022, Medtronic LABS, which is a health systems developer, announced its partnership with Ministry of Health of Kenya in order to provide health information, medication needs, and clinical support to more than 300,000 patients in all 47 counties of the country. This partnership is expected to utilize screening, diagnostic, and risk analysis technologies of Medtronic. Cooperation of systems innovator with MoH has brought other partners such as World Diabetes Foundation, Kenya Defeat Diabetes Association, PATH, Novo Nordisk, Novartis, Viatris, and NCD Alliance of Kenya on board.
Segments Covered in the report
This report offers historical data and forecasts revenue growth at a global, regional, and country-level, and provides an analysis of market trends in each of sub-segments from 2022 to 2030. For the purpose of this report, Reports and Data has segmented the global surgical glue market based on product type, application, end-use, and region:
Surgical Glue Market Report Scope
Segments covered By Product Type Outlook, Application Outlook, End-use Outlook, Regional Outlook
By Product Type Outlook
Synthetic and Semi-Synthetic Adhesives and Sealants
Natural Adhesives and Sealants
By Application Outlook
Liver and Spleen Lacerations
By End-use Outlook
Ambulatory Surgical Centers
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/119032/1500
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: